Trial intelligence / Profile preview

Exparel vs Bupivacaine for Interscalene Block in Shoulder Arthroscopy

NCT02554357Completed

Sponsor
North American Center for Continuing Medical Education
Start
Jul 2015
Primary completion
Jan 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of bupivacaine in postoperative pain, sponsored by North American Center for Continuing Medical Education. Primary endpoints: Worst pain score and Overall Benefit of Analgesia Score. Started Jul 2015; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02554357.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02554357.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call